These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27987042)

  • 1. Using dendritic cells to evaluate how Burkholderia cenocepacia clonal isolates from a chronically infected cystic fibrosis patient subvert immune functions.
    Guadalupe Cabral M; Pereira M; Silva Z; Iria I; Coutinho C; Lopes A; Sá-Correia I; Videira PA
    Med Microbiol Immunol; 2017 Apr; 206(2):111-123. PubMed ID: 27987042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of innate immune cell functions by the Burkholderia cepacia complex: Burkholderia cenocepacia but not Burkholderia multivorans disrupts maturation and induces necrosis in human dendritic cells.
    MacDonald KL; Speert DP
    Cell Microbiol; 2008 Oct; 10(10):2138-49. PubMed ID: 18624797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis.
    Miller RR; Hird TJ; Tang P; Zlosnik JE
    PLoS One; 2015; 10(11):e0143472. PubMed ID: 26599356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.
    Coutinho CP; Dos Santos SC; Madeira A; Mira NP; Moreira AS; Sá-Correia I
    Front Cell Infect Microbiol; 2011; 1():12. PubMed ID: 22919578
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hassan AA; Coutinho CP; Sá-Correia I
    Front Cell Infect Microbiol; 2019; 9():273. PubMed ID: 31417878
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation.
    Mesureur J; Feliciano JR; Wagner N; Gomes MC; Zhang L; Blanco-Gonzalez M; van der Vaart M; O'Callaghan D; Meijer AH; Vergunst AC
    PLoS Pathog; 2017 Jun; 13(6):e1006437. PubMed ID: 28651010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host evasion by Burkholderia cenocepacia.
    Ganesan S; Sajjan US
    Front Cell Infect Microbiol; 2011; 1():25. PubMed ID: 22919590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs.
    Truxova I; Pokorna K; Kloudova K; Partlova S; Spisek R; Fucikova J
    Immunol Lett; 2014 Jul; 160(1):39-49. PubMed ID: 24726860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia cenocepacia-induced delay of acidification and phagolysosomal fusion in cystic fibrosis transmembrane conductance regulator (CFTR)-defective macrophages.
    Lamothe J; Valvano MA
    Microbiology (Reading); 2008 Dec; 154(Pt 12):3825-3834. PubMed ID: 19047750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia.
    Mil-Homens D; Bernardes N; Fialho AM
    FEMS Microbiol Lett; 2012 Mar; 328(1):61-9. PubMed ID: 22150831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Burkholderia cenocepacia Type VI Secretion System Effector TecA Is a Virulence Factor in Mouse Models of Lung Infection.
    Loeven NA; Perault AI; Cotter PA; Hodges CA; Schwartzman JD; Hampton TH; Bliska JB
    mBio; 2021 Oct; 12(5):e0209821. PubMed ID: 34579569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method for investigating Burkholderia cenocepacia infections in patients with cystic fibrosis and other chronic diseases of the airways.
    Wijers CD; Vagedes R; Weingart C
    BMC Microbiol; 2016 Sep; 16(1):200. PubMed ID: 27586172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of MMP-9 by human lung epithelial cells in response to the cystic fibrosis-associated pathogen Burkholderia cenocepacia reduced wound healing in vitro.
    Wright C; Pilkington R; Callaghan M; McClean S
    Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L575-86. PubMed ID: 21743026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis.
    Abdulrahman BA; Khweek AA; Akhter A; Caution K; Kotrange S; Abdelaziz DH; Newland C; Rosales-Reyes R; Kopp B; McCoy K; Montione R; Schlesinger LS; Gavrilin MA; Wewers MD; Valvano MA; Amer AO
    Autophagy; 2011 Nov; 7(11):1359-70. PubMed ID: 21997369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.
    Coutinho CP; Barreto C; Pereira L; Lito L; Melo Cristino J; Sá-Correia I
    J Med Microbiol; 2015 Aug; 64(8):927-935. PubMed ID: 26002942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
    Drevinek P; Mahenthiralingam E
    Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of Burkholderia cenocepacia at the time of cepacia syndrome: loss of motility as a marker of poor prognosis?
    Kalferstova L; Kolar M; Fila L; Vavrova J; Drevinek P
    J Clin Microbiol; 2015 May; 53(5):1515-22. PubMed ID: 25694518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection.
    Moreira AS; Mil-Homens D; Sousa SA; Coutinho CP; Pinto-de-Oliveira A; Ramos CG; Dos Santos SC; Fialho AM; Leitão JH; Sá-Correia I
    Virulence; 2017 Aug; 8(6):782-796. PubMed ID: 27652671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient.
    Coutinho CP; de Carvalho CC; Madeira A; Pinto-de-Oliveira A; Sá-Correia I
    Infect Immun; 2011 Jul; 79(7):2950-60. PubMed ID: 21536796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.
    Kovats S; Turner S; Simmons A; Powe T; Chakravarty E; Alberola-Ila J
    Clin Exp Immunol; 2016 Nov; 186(2):214-226. PubMed ID: 27513522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.